ATHN 16: Safety of Coagulation Factor VIIa (recombinant)-Jncw for the Treatment of Bleeding Events in Patients with Congenital Hemophilia A or B with Inhibitors, with or without Prophylactic Treatment

Tammuella Christenery-Singleton, W Allan Alexander, Ahmad Al-Sabbagh, Daniel Bonzo, Michael Callaghan, Miguel Escobar, Adam Giermasz, M Nikki Hirsh, Janna Journeycake, Sonia Nasr, Rajiv Pruthi, Doris Quon, Amina Rafique, Mark Reding, Spencer Sullivan, Michael Recht
ISTH 2022 Congress
July 9-13, 2022
Safety, Eptacog-Beta

Can’t find what you’re looking for?
Please contact for assistance.